drugset
drugset / Trial / NCT04034615

The Long-term Effect of Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars

NCT04034615 ↗

Phase 2 Withdrawn Maternal and Child Health Hospital of Foshan
RandomizedParallel-groupTriple-blindTreatment

Summary

The study is to investigate the long-term efficacy of perinatal tissue mesenchyme stem cells treatment on the appearance of a caesarean scar as compared to a similar untreated scar.

Timeline

Start
2021-05-20
Primary completion
2021-12-01
Completion
2022-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “The pandemic resulted in no enrollments。”

Drugs

EvaluationDrugModalityDoseRoute
Subject Perinatal Tissue Mesenchyme Stem Cells Unknown 3e+06 cells Other
Subject Perinatal Tissue Mesenchyme Stem Cells Unknown 6e+06 cells Other

Indications

No indication recorded.